Health insurer Humana is shaking up the ownership of its senior primary care business. The company announced a new joint venture with BlackRock's HPS Investment Partners that will own and operate nearly 150 CenterWell Senior Primary Care clinics. As part of the deal, HPS will pay $2.8 billion to acquire the stake currently held by private equity firm Welsh, Carson, Anderson & Stowe.
CenterWell, Humana's care delivery arm, will retain a minority ownership position and continue to manage the clinics' day-to-day operations. The new arrangement replaces Humana's previous clinic ventures with Welsh Carson, which had been a partner in building out the network. HPS will become the majority owner, but CenterWell will remain the operator, ensuring continuity for patients and staff.
What's behind the deal?
For Humana, this move is about raising capital to fuel growth without taking on more debt or diluting shareholders. By bringing in a deep-pocketed investor like HPS, Humana can fund the expansion of its senior care clinics—opening new locations, upgrading existing sites, and pursuing acquisitions—while keeping its operational expertise in charge.
HPS, a unit of BlackRock, is a major player in private credit and alternative investments. The firm has been increasingly active in health care, a sector that offers steady, long-term cash flows. For HPS, the joint venture provides a way to deploy capital in a growing area of health care: value-based primary care for seniors, which focuses on keeping patients healthy and out of expensive hospital stays.
The deal also includes a notable option: CenterWell has the right to buy the clinics back in 2028. That gives Humana a potential path to regain full control down the road, while benefiting from HPS's capital in the meantime.
Why senior primary care matters
CenterWell Senior Primary Care clinics are designed specifically for older adults, often those on Medicare Advantage plans. These clinics typically offer a more holistic approach, with longer appointments, care coordination, and social services. The model is seen as a way to improve health outcomes while controlling costs—a key goal for insurers like Humana that are paid a fixed amount per Medicare Advantage member.
The senior care market is growing as the U.S. population ages. The number of Americans over 65 is projected to rise steadily over the next decade, driving demand for primary care services tailored to their needs. That demographic tailwind is one reason investors are interested in the space.
For Humana, the joint venture is part of a broader strategy to expand its care delivery footprint. The company has been investing heavily in clinics and other health services, betting that owning the care experience will help it manage costs and attract more Medicare Advantage members.
What it means for investors
For everyday investors, this deal is a reminder that health insurers are increasingly looking beyond traditional insurance premiums. By partnering with private capital, Humana can grow its clinic network without straining its balance sheet. That could be positive for shareholders if the clinics generate strong returns and help the company compete in the Medicare market.
However, there are risks. Joint ventures can be complex, and the 2028 buyback option means Humana may eventually need to spend significant capital to regain full ownership. If the clinics underperform, the deal could become a drag on earnings. Investors should watch how the partnership performs over the next few years, especially as HPS's involvement brings a focus on financial returns.
The deal also highlights the growing role of private credit and alternative asset managers in health care. BlackRock's HPS is part of a wave of investment firms pouring money into clinics, hospitals, and other care facilities. This trend could reshape how health care is financed and delivered, with implications for patients and investors alike.
For those holding Humana stock, the key question is whether this partnership will accelerate growth without sacrificing quality. The company has said it will continue to operate the clinics as before, which should reassure patients. But the ultimate test will be in the numbers: clinic occupancy, patient outcomes, and financial performance.
As with any major corporate deal, there are no guarantees. But for Humana, bringing in a heavyweight like BlackRock is a vote of confidence in the future of senior primary care. It's a bet that the aging population will need more—and better—care, and that private capital can help deliver it.
